Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy
Open Access
- 1 April 2018
- journal article
- research article
- Published by Elsevier BV in Heart Failure Clinics
- Vol. 14 (2), 139-146
- https://doi.org/10.1016/j.hfc.2017.12.004
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Perturbed Length-Dependent Activation in Human Hypertrophic Cardiomyopathy With Missense Sarcomeric Gene MutationsCirculation Research, 2013
- Subtle Abnormalities in Contractile Function Are an Early Manifestation of Sarcomere Mutations in Dilated CardiomyopathyCirculation: Cardiovascular Genetics, 2012
- Truncations of Titin Causing Dilated CardiomyopathyThe New England Journal of Medicine, 2012
- Muscle Giants: Molecular Scaffolds in SarcomerogenesisPhysiological Reviews, 2009
- Cardiac Myosin-Binding Protein C Mutations and Hypertrophic CardiomyopathyCirculation, 2009
- Three-Dimensional Reconstruction of Tarantula Myosin Filaments Suggests How Phosphorylation May Regulate Myosin ActivityJournal of Molecular Biology, 2008
- Head–Head and Head–Tail Interaction: A General Mechanism for Switching Off Myosin II Activity in CellsMolecular Biology of the Cell, 2008
- Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor functionProceedings of the National Academy of Sciences of the United States of America, 2006
- Atomic model of a myosin filament in the relaxed stateNature, 2005
- Structural and functional studies of titin’s fn3 modules reveal conserved surface patterns and binding to myosin S1 - a possible role in the frank-starling mechanism of the heartJournal of Molecular Biology, 2001